A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms.

Extensive research into circadian rhythms and their influence on biological systems has given rise to the science of chronobiology and subsequently chronotherapy, the science of delivering drugs in synchrony with biological rhythms. The field of chronotherapeutics paves the way for advances and complexities in current drug delivery technology. The ultimate goal of current chronopharmaceutical research strives to design ideal chronotherapeutic drug delivery systems that respond to such therapeutic needs. Considering the fact that physiological events such as heart rate, blood pressure, plasma concentration of hormones, plasma proteins and enzymes display constancy over time, drug delivery systems with constant release profiles have thus been favored. However, due to circadian rhythms, the conventional paradigm of constant drug delivery may not be what is needed. Instead, precisely timed drug delivery systems are required in order to correlate drug delivery with circadian rhythms to provide maximum therapeutic efficacy for chronotherapeutic diseases when most needed. The aim of this review paper is to outline the concepts in designing chronopharmaceuticals from a clinical viewpoint of major chronotherapeutic diseases such as asthma, allergic rhinitis, cardiovascular disorders, rheumatoid arthritis and cancer as well as relatively minor niche areas of interest such as in glaucoma, diabetes, immunity, pain, gastric ulcers, epilepsy and even HIV/AIDS that would require chronotherapy. In addition this review paper attempts to concisely assimilate and explicate the role of circadian rhythms in these various disease states and provide a focused overview of the current state-of-the-art in designing strategies for chronopharmaceutical formulations employed for treating chronotherapeutic diseases.

[1]  A. Prończuk,et al.  Nutritional correlates and dynamics of diabetes in the Nile rat (Arvicanthis niloticus): a novel model for diet-induced type 2 diabetes and the metabolic syndrome , 2010, Nutrition & Metabolism.

[2]  Sobia Rana,et al.  Circadian rhythm and its role in malignancy , 2010, Journal of circadian rhythms.

[3]  P. Burge Recent developments in occupational asthma. , 2010, Swiss medical weekly.

[4]  M. Beckett,et al.  Mechanisms by which circadian rhythm disruption may lead to cancer , 2010 .

[5]  V. Lotlikar,et al.  Pulsatile delivery systems: An approach for chronotherapeutic diseases , 2010 .

[6]  A. Chacko,et al.  Chronotherapeutics and Chronotherapeutic Drug Delivery Systems , 2009 .

[7]  J. Sabarinathan,et al.  Near-infrared optical response of thin film pH-sensitive hydrogel coated on a gold nanocrescent array. , 2009, Optics express.

[8]  V. Pillay,et al.  Drug delivery technologies for chronotherapeutic applications , 2009, Pharmaceutical development and technology.

[9]  M. Fujii,et al.  Novel chronotherapeutic rectal aminophylline delivery system for therapy of asthma. , 2009, International journal of pharmaceutics.

[10]  J. Kenny,et al.  Stimuli responsive hydrogels prepared by frontal polymerization. , 2009, Biomacromolecules.

[11]  M. Geetha,et al.  Optimization and Development of Swellable Controlled Porosity Osmotic Pump Tablet for Theophylline , 2009 .

[12]  M. Bonsignore,et al.  Metabolic aspects of obstructive sleep apnoea syndrome , 2009, European Respiratory Review.

[13]  Aliasgar Shahiwala,et al.  Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[14]  P. Colombo,et al.  Novel Platforms for Oral Drug Delivery , 2009, Pharmaceutical Research.

[15]  H. Frijlink,et al.  Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[16]  L. Geddes Circadian rhythms provide guide for cancer therapies , 2008 .

[17]  Xing Tang,et al.  In vitro and in vivo evaluation of ofloxacin sustained release pellets. , 2008, International journal of pharmaceutics.

[18]  J. Nie,et al.  A pH‐sensitive water‐soluble N‐carboxyethyl chitosan/poly(hydroxyethyl methacrylate) hydrogel as a potential drug sustained release matrix prepared by photopolymerization technique , 2008 .

[19]  M. Ishida,et al.  A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules. , 2008, International journal of pharmaceutics.

[20]  P. Mura,et al.  Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  Tetsuo Shimizu,et al.  Expression profiles of 10 circadian clock genes in human peripheral blood mononuclear cells , 2008, Neuroscience Research.

[22]  M. Shoaib,et al.  Formulation development and optimization of Ibuprofen tablets by direct compression method. , 2008, Pakistan journal of pharmaceutical sciences.

[23]  T. Velten,et al.  Drug delivery from the oral cavity: focus on a novel mechatronic delivery device. , 2008, Drug discovery today.

[24]  Linfeng Wu,et al.  Surface crosslinking for delayed release of proxyphylline from PHEMA hydrogels. , 2008, International journal of pharmaceutics.

[25]  J. Jacobs,et al.  Glucocorticoid chronotherapy in rheumatoid arthritis , 2008, The Lancet.

[26]  F. Turek,et al.  Sleep and circadian rhythms: Key components in the regulation of energy metabolism , 2008, FEBS letters.

[27]  R. Minutolo,et al.  Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  Francesco Portaluppi,et al.  Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. , 2007, Advanced drug delivery reviews.

[29]  B. Bruguerolle,et al.  Rhythmic pattern in pain and their chronotherapy. , 2007, Advanced drug delivery reviews.

[30]  Michael H Smolensky,et al.  Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. , 2007, Advanced drug delivery reviews.

[31]  Francis Lévi,et al.  Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. , 2007, Advanced drug delivery reviews.

[32]  Nicholas A Peppas,et al.  Chronobiology, drug delivery, and chronotherapeutics. , 2007, Advanced drug delivery reviews.

[33]  O. Froy The relationship between nutrition and circadian rhythms in mammals , 2007, Frontiers in Neuroendocrinology.

[34]  D. Puleo,et al.  Bioerodible devices for intermittent release of simvastatin acid. , 2007, International journal of pharmaceutics.

[35]  S. Ponrathnam,et al.  Low density porous carrier based conceptual drug delivery system , 2007 .

[36]  J. Stehle,et al.  The mammalian pineal gland: known facts, unknown facets , 2007, Trends in Endocrinology & Metabolism.

[37]  N. Ishida Circadian clock, cancer and lipid metabolism , 2007, Neuroscience Research.

[38]  G. Marshall,et al.  Montelukast in the management of allergic rhinitis , 2007, Therapeutics and clinical risk management.

[39]  A. R. Kulkarni,et al.  Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. , 2007, International journal of pharmaceutics.

[40]  Wei Wu,et al.  Characterization of 5-Fluorouracil Release from Hydroxypropylmethylcellulose Compression-Coated Tablets , 2007, Pharmaceutical development and technology.

[41]  James Lyons-Weiler,et al.  Molecular overlap of fly circadian rhythms and human pancreatic cancer. , 2006, Cancer letters.

[42]  K. Kadota,et al.  Clock mutation affects circadian regulation of circulating blood cells , 2006, Journal of circadian rhythms.

[43]  A. Dashevsky,et al.  Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquacoat ECD. , 2006, International journal of pharmaceutics.

[44]  A. Pawar,et al.  Low density multiparticulate system for pulsatile release of meloxicam. , 2006, International journal of pharmaceutics.

[45]  D. Bikiaris,et al.  Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. , 2006, International journal of pharmaceutics.

[46]  M. Vlachou,et al.  Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release. , 2006, International journal of pharmaceutics.

[47]  N. Peppas,et al.  Assemblage of novel release modules for the development of adaptable drug delivery systems. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[48]  C. Takimoto Chronomodulated chemotherapy for colorectal cancer: failing the test of time? , 2006, European journal of cancer.

[49]  J. Krueger,et al.  Links between the innate immune system and sleep. , 2005, The Journal of allergy and clinical immunology.

[50]  Ueli Schibler,et al.  The daily rhythms of genes, cells and organs , 2005, EMBO reports.

[51]  Johannes D Veldhuis,et al.  Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. , 2005, Diabetes.

[52]  R. Hermida,et al.  Chronotherapy Improves Blood Pressure Control and Reverts the Nondipper Pattern in Patients With Resistant Hypertension , 2008, Hypertension.

[53]  H. Sekhon,et al.  Vitamin C prevents the effects of prenatal nicotine on pulmonary function in newborn monkeys. , 2005, American journal of respiratory and critical care medicine.

[54]  R. Hermida,et al.  P-149: Administration time-dependent effects of amlodipine on ambulatory blood pressure in patients with essential hypertension , 2005 .

[55]  R. Hermida,et al.  OR-6: Administration time-dependent efficacy of valsartan-atorvastatin combination in hyperlipidemic patients with essential hypertension , 2005 .

[56]  R. Hermida,et al.  P-150: Differing effects of awakening versus bedtime valsartan administration on urinary albumin excretion in hypertensive patients , 2005 .

[57]  C. Green Time for chronotherapy? Clock genes dictate sensitivity to cyclophosphamide. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[58]  V. Stella,et al.  Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs) , 2004 .

[59]  J. Born,et al.  Preserved circadian rhythm of serum insulin concentration at low plasma glucose during fasting in lean and overweight humans. , 2004, Metabolism: clinical and experimental.

[60]  W. Storms Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. , 2004, The Journal of allergy and clinical immunology.

[61]  A. Rawat,et al.  Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. , 2004, International journal of pharmaceutics.

[62]  X. Zhu,et al.  Polymer microspheres for controlled drug release. , 2004, International journal of pharmaceutics.

[63]  M. P. Danckwerts,et al.  A novel compression-coated doughnut-shaped tablet design for zero-order sustained release. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[64]  F. Lévi,et al.  It is time for chronotherapy! , 2003, Pathologie-biologie.

[65]  R. Singh,et al.  Circadian variation of basal total vascular tone and chronotherapy in patients with vasospastic angina pectoris. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[66]  G. Skloot Nocturnal asthma: mechanisms and management. , 2002, The Mount Sinai journal of medicine, New York.

[67]  S. Garg,et al.  Formulation aspects in the development of osmotically controlled oral drug delivery systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[68]  M. Weber The 24-hour blood pressure pattern: does it have implications for morbidity and mortality? , 2002, The American journal of cardiology.

[69]  E. Shimizu,et al.  Theophylline chronotherapy of nocturnal asthma using bathyphase of circadian rhythm in peak expiratory flow rate. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[70]  B. Lemmer Relevance for chronopharmacology in practical medicine. , 2000, Seminars in perinatology.

[71]  K. Zhu,et al.  Pulsatile protein release from a laminated device comprising polyanhydrides and pH-sensitive complexes. , 2000, International journal of pharmaceutics.

[72]  J. Cui,et al.  Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings. , 1999, International journal of pharmaceutics.

[73]  M. Smolensky,et al.  Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. , 1999, American heart journal.

[74]  R. Lockey,et al.  Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes. , 1999, Chest.

[75]  S. Neau,et al.  Sustained release theophylline tablets by direct compression: Part 1: formulation and in vitro testing , 1998 .

[76]  R. Martin,et al.  Further studies on the chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. , 1997, The Journal of allergy and clinical immunology.

[77]  M. Tobyn,et al.  Influence of processing variables on physical properties of timerx , 1996 .

[78]  Richard W. Baker,et al.  Osmotic drug delivery : a review of the patent literature , 1995 .

[79]  L. Ackerson,et al.  Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. , 1995, The Journal of allergy and clinical immunology.

[80]  S. Soong,et al.  The time of administration of 3'-azido-3'-deoxythymidine (AZT) determines its host toxicity with possible relevance to AZT chemotherapy , 1993, Antimicrobial Agents and Chemotherapy.

[81]  W. R. Beam,et al.  Timing of prednisone and alterations of airways inflammation in nocturnal asthma. , 1992, The American review of respiratory disease.

[82]  G. Zentner,et al.  Controlled porosity solubility- and resin-modulated osmotic drug delivery systems for release of diltiazem hydrochloride , 1991 .

[83]  M. Turner-Warwick,et al.  Epidemiology of nocturnal asthma. , 1988, The American journal of medicine.

[84]  W. Arkinstall Review of the North American experience with evening administration of Uniphyl tablets, a once-daily theophylline preparation, in the treatment of nocturnal asthma. , 1988, The American journal of medicine.

[85]  S. Leslie The Contin delivery system: dosing considerations. , 1986, The Journal of allergy and clinical immunology.

[86]  M. Smolensky,et al.  Clinical significance of day-night differences in serum theophylline concentration with special reference to Theo-Dur. , 1986, The Journal of allergy and clinical immunology.

[87]  M. Knapp,et al.  Lymphocytes are rhythmic: is this important? , 1984, British medical journal.

[88]  A. Pradalier,et al.  Pharmacokinetics of theophylline in night-workers. , 1982, British journal of clinical pharmacology.

[89]  E. Raftery,et al.  CIRCADIAN VARIATION OF BLOOD-PRESSURE , 1978, The Lancet.

[90]  R. Haag,et al.  Pharmaceutically used polymers: principles, structures, and applications of pharmaceutical delivery systems. , 2010, Handbook of experimental pharmacology.

[91]  M. An,et al.  Formulation and Evaluation of Timed Delayed Capsule Device for Chronotherapeutic Delivery of Terbutaline Sulphate , 2010 .

[92]  D. Bikiaris,et al.  Recent advances in oral pulsatile drug delivery. , 2009, Recent patents on drug delivery & formulation.

[93]  K. Reddy,et al.  REVIEW ON: PULSATILE DRUG DELIVERY SYSTEMS , 2009 .

[94]  A. Gazzaniga,et al.  Oral pulsatile delivery systems based on swellable hydrophilic polymers. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[95]  R. Straub,et al.  Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction. , 2008, Autoimmunity reviews.

[96]  P. Sher,et al.  Development of hollow/porous calcium pectinate beads for floating-pulsatile drug delivery. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[97]  D. Generali,et al.  The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load. , 2007, Bone.

[98]  M. Turkoğlu,et al.  In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[99]  M. Weber,et al.  A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. , 2001, American journal of hypertension.

[100]  M. Smolensky,et al.  Biological Rhythms and Medicine , 1983, Topics in Environmental Physiology and Medicine.